FDA de­clines to is­sue fines for non­com­pli­ant tri­al re­port­ing

The FDA said it won’t im­pose fines or take greater en­force­ment ac­tion against clin­i­cal tri­al spon­sors when they fail to prop­er­ly re­port tri­al in­for­ma­tion to the gov­ern­ment. The agency said it will in­stead con­tin­ue to urge vol­un­tary com­pli­ance, ac­cord­ing to a cit­i­zen pe­ti­tion re­sponse filed Wednes­day.

The 30-page pe­ti­tion, filed last Feb­ru­ary by the Uni­ver­si­ties Al­lied for Es­sen­tial Med­i­cines, as­serts that the FDA’s en­force­ment of clin­i­cal tri­al re­port­ing has been min­i­mal and lacks fo­cus.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER